About us – Sonovum wordpress

Collaborating for excellence

Our operating model is built to be lean, expert-driven and results-focused - combining our internal core strengths in signal science, clinical product strategy and regulatory excellence with strong industrial, research and clinical partners along the way.

This integrated model ensures top-tier expertise at every stage of development and scale-up – enabling high quality, reliability and global scalability.

Our Mission

We turn complex brain physiology into clear, actionable information — enabling faster, evidence-based decisions in every care setting.

Our Vision

Critical brain insights within minutes — non-invasive, safe, and globally accessible.

Sonovum's Core Values

These principles guide how we work, make decisions, and build technology - every day.

Patient First

We design to improve patient safety, quality of care, and ultimately save lives.

Build Together

We operate as one team - combining diverse skills to co-create solutions and move faster and smarter together.

Act with Scientific Integrity

We let evidence, data quality, and transparency guide every decision.

Make Complexity Simple

We turn biosignals into clear, understandable information that fits clinical workflows.

Innovate with Purpose

We challenge conventions to create meaningful, non-invasive solutions that change patient care.

Think Global

We build scalable solutions to make life-saving brain diagnostics accessible to anyone, anywhere.

Meet our Managing Directors

Experienced innovators with a shared belief: technology only matters if it improves clinical outcomes.

Bertram König

CEO

bertram.koenig@sonovum.de

As CEO, Bertram brings a proven track record in executive leadership roles within leading MedTech companies - with a deep understanding of innovation, value creation and market adoption in this industry.
He is fluent in both start-up and corporate environments and knows how to combine ambition with disciplined, reality-based execution.
Having first supported the company as a board advisor and now leading it as CEO for over five years, he has played a central role in shaping its development, building capabilities and driving its strategic progress.

Manuela Franke

CFO

manuela.franke@sonovum.de

As CFO, Manuela brings a strong track record in value creation from mid-size companies, as part of the executive leadership team she contributed to significant increase in revenue and drive sustainable growth. Her background in HR, communication, strategy, U.S. business environments and M&A enables her to build organizations that scale - by developing talent, aligning teams, and unlocking performance.
In our company, she ensures capital efficiency, strategic focus and the disciplined execution required to translate innovation into lasting enterprise value.

Guided by Leading Clinicians

Our Medical Advisory Board and Key Opinion Leaders bring together internationally recognized experts in neurosurgery, intensive care, and neurology – ensuring that our development is driven by real clinical needs and evidence-based insight.

Bernhard Meyer, MD

Chairman of the Department of Neurosurgery

Peter Vajkoczy, MD

Chairman of the Department of Neurosurgery

Karl Schaller, MD

Chairman of the Department of Neurosurgery

Andreas Hetzel, MD

Chairman of the Department of Neurology

About us

Join our team

Our People, Our Power

At Sonovum GmbH, we combine scientific precision, technological innovation, and clinical experience to shape the diagnostics of tomorrow. Our interdisciplinary structure unites regulatory expertise, clinical validation, artificial intelligence, software development, biosignal research, signal processing, and data management into one seamless development process, from initial concept to certified medical product.

Explore Our Technology

Join our team

Artificial Intelligence

Our AI team transforms complex biosignal data into clinically meaningful insights, advancing non-invasive diagnostics through the fusion of machine learning and biomedical expertise.

Software Development – The Intelligent Interface

Our software development team builds the bridge between AI, users, and clinical practice. They ensure that complex analytical processes are clear, secure, and intuitive to use.

Regulatory & Clinical Affairs

Our Regulatory and Clinical Affairs team ensures compliance with international standards such as FDA and MDR, prioritizing patient safety and ethical integrity. In collaboration with clinical partners, we conduct studies that confirm the safety, efficacy, and market readiness of our technology.

Biosignal Expertise

Our team has strong capabilities in biosignal processing, feature extraction, and pattern recognition, enabling the transformation of raw physiological signals into validated clinical insights.

Our Sonovum Story

2020 – 2023

Technology and Product Development

While our company had already been active in medical technology before, 2020 marked a strategic refocus on developing a non-invasive solution for intracranial pressure assessment.

Between 2020 and 2023, we advanced the core technology, combining biosignal expertise, transmission ultrasound, and AI-supported model development to create a clinically robust, stand-alone device platform designed for neurological applications.

2024 – 2025

Clinical Validation

In 2024, our technology entered clinical validation in Germany, conducted in collaboration with leading university hospitals specializing in neurosurgery.

The study focuses on patients with traumatic brain injury (TBI) and aims to demonstrate the performance, safety, and clinical value of avoiding unnecessary invasive probes.

Completion is expected in January 2026, providing the clinical evidence required for CE marking under the European Medical Device Regulation (MDR).

2026

Product Launch

Following successful validation and CE certification expected in Q4 2026, we plan to introduce our stand-alone device to the European market.

The initial rollout will target leading neurotrauma and intensive care centers, establishing clinical reference sites and preparing for scale-up and broader adoption.

2027 and beyond

Expansion and Future Applications

Building on our validated platform, we aim to expand both clinically and geographically.

Future developments may include additional neurological and emergency-care applications, as well as use in field settings such as sports and military environments — each to be validated and approved according to regulatory standards.

Geographical expansion will begin in Europe, followed by North America and Asia, supported by strong clinical data, strategic partnerships, and a growing network of key opinion leaders.

Committed to save lives

Collaborating for excellence

Our Mission

Our Vision

Our partners

Sonovum's Core Values

Patient First

Build Together

Act with Scientific Integrity

Make Complexity Simple

Innovate with Purpose

Think Global

Meet our Managing Directors

Bertram König

Manuela Franke

Guided by Leading Clinicians

Our People, Our Power

Artificial Intelligence

Software Development – The Intelligent Interface

Regulatory & Clinical Affairs

Biosignal Expertise

Our Sonovum Story

Technology and Product Development

Clinical Validation

Product Launch

Expansion and Future Applications

Ready to revolutionize brain monitoring?